Expanded phenotypic and hematologic abnormalities beyond bone marrow failure in MECOM-associated syndromes

Am J Med Genet A. 2023 Jul;191(7):1826-1835. doi: 10.1002/ajmg.a.63208. Epub 2023 Apr 17.

Abstract

The MECOM gene encodes multiple protein isoforms that are essential for hematopoietic stem cell self-renewal and maintenance. Germline MECOM variants have been associated with congenital thrombocytopenia, radioulnar synostosis and bone marrow failure; however, the phenotypic spectrum of MECOM-associated syndromes continues to expand and novel pathogenic variants continue to be identified. We describe eight unrelated patients who add to the previously known phenotypes and genetic defects of MECOM-associated syndromes. As each subject presented with unique MECOM variants, the series failed to demonstrate clear genotype-to-phenotype correlation but may suggest a role for additional modifiers that affect gene expression and subsequent phenotype. Recognition of the expanded hematologic and non-hematologic clinical features allows for rapid molecular diagnosis, early identification of life-threatening complications, and improved genetic counseling for families. A centralized international publicly accessible database to share annotated MECOM variants would advance their clinical interpretation and provide a foundation to perform functional MECOM studies.

Keywords: MECOM; aplastic anemia; bone marrow failure; inherited bone marrow failure syndrome; radioulnar synostosis; thrombocytopenia.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Bone Marrow Diseases* / diagnosis
  • Bone Marrow Diseases* / genetics
  • Bone Marrow Failure Disorders
  • Hematologic Diseases*
  • Humans
  • MDS1 and EVI1 Complex Locus Protein / genetics
  • Pancytopenia*
  • Phenotype
  • Syndrome
  • Transcription Factors / genetics

Substances

  • Transcription Factors
  • MECOM protein, human
  • MDS1 and EVI1 Complex Locus Protein